NCT04706793 Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN) Status COMPLETED Phase PHASE3
NCT04703920 Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian Cancer Status COMPLETED Phase PHASE1
NCT04697381 Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWS Status COMPLETED Phase PHASE3
NCT04690855 A Study to Evaluate TAlazoparib, Radiotherapy and Atezolizumab in gBRCA 1/2 Negative Patients With PD-L1+ Metastatic Triple Negative Breast Cancer Status TERMINATED Phase PHASE2
NCT04682639 A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic Esophagitis Status COMPLETED Phase PHASE2
NCT04682587 To Examine the Effects of Axitinib Dose Reduction and Interruption for Adverse Event Management Among Patients Receiving Axitinib in for the Treatment of Advanced Renal Cell Carcinoma Status COMPLETED Phase N/A
NCT04681482 Effectiveness And Safety Of Oral Anticoagulants Among Obese Patients With Non-Valvular A-Fib In VA Patients With Medicare Status COMPLETED Phase N/A
NCT04678362 TALazoparib and Avelumab as Maintenance Therapy in Platinum-Sensitive Metastatic or Locally Advanced URothelial Carcinoma Status RECRUITING Phase PHASE2
NCT04672460 A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT04671615 A Study to Understand the Treatment Patterns and Patients and Their Clinical Outcomes Who Are Taking Palbociclib in a Real Life Setting in Israel. Status COMPLETED Phase N/A
NCT04669366 Treatment Patterns With Targeted Therapies In Mrcc In Sweden - A Retrospective Analysis Of Data From National Registries Status COMPLETED Phase N/A
NCT04668066 Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis Status COMPLETED Phase PHASE1
NCT04664556 National, Non Interventional Study of Invasive Pneumococcal Disease in Children and Newborns Status RECRUITING Phase N/A
NCT04664153 Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT04657991 A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04655040 Estimation of the Effect of Multiple Dose Ritlecitinib (PF-06651600) on the Pharmacokinetics of a Single Dose of Caffeine in Healthy Participants Status COMPLETED Phase PHASE1
NCT04649359 MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb Status ACTIVE_NOT_RECRUITING Phase PHASE2